A Study of PN20 in Healthy Adult Volunteers

Clinical trial NCT06523088 · COMPLETED

Trial details

NCT number: NCT06523088
Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Thrombocytopenia Immune Thrombocytopenic Purpura

Start date: 2022-06-16
Primary completion: 2023-01-05
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.